Literature DB >> 9929564

Insulin modulation of ATP-sensitive K+ channel of rat skeletal muscle is impaired in the hypokalaemic state.

D Tricarico1, R Capriulo, D Conte Camerino.   

Abstract

In the present work, we examined the effects of in vivo administration of insulin to rats made hypokalaemic by feeding a K+-free diet. The i.p. injection of insulin in the hypokalaemic rats provoked muscle paralysis within 3-5 h. Consistent with this observation, the skeletal muscle fibres of the paralysed rats were depolarized. In contrast, in the normokalaemic animals, insulin neither provoked paralysis nor produced significant fibre hyperpolarization. In the hypokalaemic rats, insulin almost completely abolished the sarcolemma adenosine triphosphate (ATP)-sensitive K+ currents without altering the sensitivity of the channels to ATP or glibenclamide. In contrast, in the normokalaemic rats, insulin enhanced ATP-sensitive K+ currents that became also resistant to ATP and glibenclamide. Our experiments indicate that the modulation of the sarcolemma ATP-sensitive K+ channels by insulin is impaired in the hypokalaemic state. This phenomenon appears to be related to the fibre depolarization and paralysis observed in the same animals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9929564     DOI: 10.1007/s004240050774

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  7 in total

1.  The human skeletal muscle Na channel mutation R669H associated with hypokalemic periodic paralysis enhances slow inactivation.

Authors:  A F Struyk; K A Scoggan; D E Bulman; S C Cannon
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

Review 2.  Skeletal muscle sodium current is reduced in hypokalemic periodic paralysis.

Authors:  R L Ruff
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

3.  A sodium channel knockin mutant (NaV1.4-R669H) mouse model of hypokalemic periodic paralysis.

Authors:  Fenfen Wu; Wentao Mi; Dennis K Burns; Yu Fu; Hillery F Gray; Arie F Struyk; Stephen C Cannon
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

4.  Acetazolamide prevents vacuolar myopathy in skeletal muscle of K(+) -depleted rats.

Authors:  D Tricarico; S Lovaglio; A Mele; G Rotondo; E Mancinelli; G Meola; D C Camerino
Journal:  Br J Pharmacol       Date:  2008-03-17       Impact factor: 8.739

5.  Impairment of skeletal muscle adenosine triphosphate-sensitive K+ channels in patients with hypokalemic periodic paralysis.

Authors:  D Tricarico; S Servidei; P Tonali; K Jurkat-Rott; D C Camerino
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

6.  Recent advances in the pathogenesis and drug action in periodic paralyses and related channelopathies.

Authors:  Domenico Tricarico; Diana Conte Camerino
Journal:  Front Pharmacol       Date:  2011-02-28       Impact factor: 5.810

7.  Pathophysiological Consequences of KATP Channel Overactivity and Pharmacological Response to Glibenclamide in Skeletal Muscle of a Murine Model of Cantù Syndrome.

Authors:  Rosa Scala; Fatima Maqoud; Nicola Zizzo; Antonietta Mele; Giulia Maria Camerino; Francesco Alfredo Zito; Girolamo Ranieri; Conor McClenaghan; Theresa M Harter; Colin G Nichols; Domenico Tricarico
Journal:  Front Pharmacol       Date:  2020-11-30       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.